BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8239562)

  • 1. Forearm 3-methylhistidine efflux in myotonic dystrophy.
    Rifai Z; Kingston WJ; McCraith B; Moxley RT
    Ann Neurol; 1993 Nov; 34(5):682-6. PubMed ID: 8239562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-methylhistidine excretion in myotonic dystrophy.
    Griggs RC; Moxley RT; Forbes GB
    Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
    McKeran RO; Halliday D; Purkiss P; Royston P
    J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myofibrillar protein degradation in the chicken. 3-Methylhistidine release in vivo and in vitro in normal and genetically muscular-dystrophic chickens.
    Hillgartner FB; Williams AS; Flanders JA; Morin D; Hansen RJ
    Biochem J; 1981 May; 196(2):591-601. PubMed ID: 7316997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting.
    Zoli M; Marchesini G; Dondi C; Bianchi GP; Pisi E
    Clin Sci (Lond); 1982 Jun; 62(6):683-6. PubMed ID: 7083759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy.
    Moxley RT; Griggs RC; Goldblatt D; VanGelder V; Herr BE; Thiel R
    J Clin Invest; 1978 Oct; 62(4):857-67. PubMed ID: 701484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractile protein breakdown in human leg skeletal muscle as estimated by [2H3]-3-methylhistidine: a new method.
    Vesali RF; Klaude M; Thunblad L; Rooyackers OE; Wernerman J
    Metabolism; 2004 Aug; 53(8):1076-80. PubMed ID: 15281022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
    Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1.
    Thornell LE; Lindstöm M; Renault V; Klein A; Mouly V; Ansved T; Butler-Browne G; Furling D
    Neuropathol Appl Neurobiol; 2009 Dec; 35(6):603-13. PubMed ID: 19207265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    McKeran RO; Halliday D; Purkiss P
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo estimation of muscle protein synthesis in myotonic dystrophy.
    Halliday D; Ford GC; Edwards RH; Rennie MJ; Griggs RC
    Ann Neurol; 1985 Jan; 17(1):65-9. PubMed ID: 3985589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of relationship of hypogonadism to muscle wasting in myotonic dystrophy.
    Griggs RC; Kingston W; Herr BE; Forbes G; Moxley RT
    Arch Neurol; 1985 Sep; 42(9):881-5. PubMed ID: 3927876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophy: effect of testosterone on total body potassium and on creatinine excretion.
    Griggs RC; Kingston W; Herr BE; Forbes G; Moxley RT
    Neurology; 1985 Jul; 35(7):1035-40. PubMed ID: 4010942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of muscle wasting in myotonic dystrophy.
    Griggs RC; Jozefowicz R; Kingston W; Nair KS; Herr BE; Halliday D
    Ann Neurol; 1990 May; 27(5):505-12. PubMed ID: 2360792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proximal myotonic dystrophy mimicking progressive muscular atrophy.
    Rotondo G; Sansone V; Cardani R; Mancinelli E; Krahe R; Stangalini D; Meola G
    Eur J Neurol; 2005 Feb; 12(2):160-1. PubMed ID: 15679706
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic implications of distal atrophy. Carbohydrate metabolism in centronuclear myopathy.
    Moxley RT; Griggs RC; Markesbery WR; Vangelder V
    J Neurol Sci; 1978 Dec; 39(2-3):247-59. PubMed ID: 739270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basal metabolic rate in myotonic dystrophy: evidence against hypometabolism.
    Jozefowicz RF; Welle SL; Nair KS; Kingston WJ; Griggs RC
    Neurology; 1987 Jun; 37(6):1021-5. PubMed ID: 3587621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myofibrillar protein degradation in premature infants with respiratory distress as assessed by 3-methylhistidine and creatinine excretions.
    Lunyong VE; Friedman Z
    Am J Clin Nutr; 1982 Sep; 36(3):485-91. PubMed ID: 7113954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skeletal muscle catabolism in amyotrophic lateral sclerosis and chronic spinal muscular atrophy.
    Corbett AJ; Griggs RC; Moxley RT
    Neurology; 1982 May; 32(5):550-2. PubMed ID: 7200211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.